Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

32.58 +0.38 (+1.18%)
Streaming Delayed Price Updated: 11:28 AM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 942,479
Open 32.37
Bid (Size) 32.57 (1)
Ask (Size) 32.58 (1)
Prev. Close 32.20
Today's Range 32.23 - 32.67
52wk Range 24.05 - 34.20
Shares Outstanding 388,132,400
Dividend Yield 2.70%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Mid-Cap Stocks Facing Headwinds
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Topics Economy
Exposures Supply Chain
Royalty Pharma Declares Second Quarter 2025 Dividend
From Royalty Pharma plc
Via GlobeNewswire

Performance

YTD
+26.3%
+26.3%
1 Month
+3.9%
+3.9%
3 Month
+2.7%
+2.7%
6 Month
+19.5%
+19.5%
1 Year
+15.9%
+15.9%

More News

Read More
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
From Royalty Pharma plc
Via GlobeNewswire
Peering Into Royalty Pharma's Recent Short Interest
Via Benzinga
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
From Royalty Pharma plc
Via GlobeNewswire
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
4 Healthcare Stocks With Massive Gains—and More to Come
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Economy Tariff
Royalty Pharma Announces Upcoming Investor Day
From Royalty Pharma plc
Via GlobeNewswire
3 Reasons to Sell RPRX and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Exposures US Equities
The Stock Market Hates Uncertainty & Loves To Climb A Wall-Of-Worry
Via Talk Markets
Topics ETFs Stocks / Equities
Uncovering Noteworthy Technical Analysis Findings for ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX).
Via Chartmill
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
3 Value Stocks in Hot Water
Via StockStory
How Do Investors Really Feel About Royalty Pharma?
Via Benzinga
Is ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX) Ready to Break Out of Its Range?
Via Chartmill
1 Stock Under $50 with Exciting Potential and 2 to Ignore
Via StockStory
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference
From Royalty Pharma plc
Via GlobeNewswire
Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
Via Benzinga
Royalty Pharma Announces R&D Funding Collaboration With Biogen
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue Estimates
Via StockStory
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
Via Benzinga
Royalty Pharma Reports Q4 and Full Year 2024 Results
From Royalty Pharma plc
Via GlobeNewswire
Earnings Scheduled For February 11, 2025
Via Benzinga

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 32.58
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 04/28/25 11:28 AM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 12.65B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.